With well over one million Americans living with Rheumatoid Arthritis, there has been an interest in developing antirheumatic treatments dating back to the 1930s, giving rise to the classification of “disease-modifying antirheumatic drugs” (DMARDs) in the 1970s and 1980s. Of course, any drug or therapy will be most effective when patients adhere to the prescribed…
Specialty drugs — often described as “prescription drugs that are difficult to manufacture and require special handling or administration, have limited distribution, target a narrow group of chronic diseases, are costly, and require ongoing clinical support — will drive nearly all of the pharmaceutical industry’s market growth from 2015–2020. Drug Channels projects the total pharmaceutical…
Complexity is the operative word in Pharm Exec’s 2017 Pipeline Report. Complex diseases are driving the development of new and innovative therapies while the market adjusts to manufacturing challenges and increasing drug costs. We’ve recapped some of the main topics in the report, including CAR-T therapies, combination treatments and nonalcoholic steatohepatitis (NASH), among others. …
Clinical trials play a vital role in finding new ways to detect and treat diseases. Without them, medical advancements won’t happen. Participants may be hesitant to participate in a clinical trial because they don’t understand the process or have misconceptions about what to expect. Here we dispel five common myths about clinical research trials. 1.…